Regarding male breast cancer, a rare disease comprising ∼1% of breast cancers, data are generally scant. The present study aimed to quantify the imaging detected breast cancer in male gender corpses, determining in this way the prevalence of silent breast cancer in male gender.
Methodology:
The population target has been male corpses without clinical expression of breast cancer. Seventy-four male corpses have been submitted to bilateral subcutaneous radical mastectomy. Samples have been submitted to echography and mammography imaging and every lesion superior to BI-RADS 4a has been excised.
Results:
One excisional biopsy has been performed and no case of breast cancer has been identified.
Discussion:
Our findings suggest that screening of the general population for male breast cancer is not necessary.
MartinsMAparícioE. Survival Analysis of Male Breast Carcinoma. Instituto Superior Técnico, Lisbon, Portugal2013.
2.
BhathalPSBrownRWLesueurGCRussellIS. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer. 1985;51(2):271–278.
3.
BartowSAPathakDRBlackWC, et al.Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer. 1987;60(11):2751–2760.
4.
BashamVMLipscombeJMWardJM. BRCA1 and BRCA2 mutations in a population-based study of male breast. Breast Cancer Res. 2002;4(1):R2.
5.
NielsenMThomsenJLPrimdahlS, et al.Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56(6):814–819.
6.
WelchHGBlackWC. Using autopsy series to estimate the disease ‘reservoir’ for ductal carcinoma in situ of the breast: how much more breast cancer can we find?Ann Intern Med. 1997;127(11):1023–1038.
7.
StalsbergHAdjeiEKOwusu-AfriyieO. No difference in the prevalence of benign breast changes between women from Ghana and Norway: an autopsy study. Breast Cancer Res Treat. 2015;151:177–182.
8.
VanderstoepSWJohnsonDD. Research Methods for Everyday Life: Blending Qualitative and Quantitative Approaches. San Francisco; 2009.
9.
CohenLManionLMorrisonK. Research Methods in Education. Taylor & Francis Group; 2007.
10.
CochranWG. Sampling Techniques. 3rd ed. John Wiley & Sons; 1977.
SidiropoulouZVasconcelosAPCouceiroC, et al.Silent Male Breast Cancer: The Natural Reservoir of the Disease in Autopsy Specimens. Mystras 24th Int Congress Advances in Oncology; 2019.
13.
Garcia-SaenzASánchez de MiguelAEspinosaA, et al.Evaluating the association between artificial light-at-night exposure and breast and prostate cancer risk in Spain (MCC-Spain study). Environ Health Perspect. 2018;126(4):1–112018.
14.
LittleMPMcElvennyDM. Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors—differences in excess relative and absolute risk from female breast cancer. Environ Health Perspect. 2017;125(2):223–229.
15.
DebSWongSQLiJ, et al.Mutational profiling of familial male breast cancers reveals similarities with luminal a female breast cancer with rare TP53 mutations. Br J Cancer. 2014;111(12):2351–2360.
16.
RabbeeZGroganS. Young men’s understandings of male breast cancer: “pink ribbons” and “war wounds. J Mens Health. 2016;15(3):210–217.
17.
FentimanISFourquetAHortobagyiGN. Male breast cancer. Lancet. 2006;367(9510):595–604.
18.
LeeUJJonesJS. Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening. Prostate Cancer Prostatic Dis. 2009;12(1):52–56.
19.
RajaVPrasadCSMurthyP. Intracystic papillary carcinoma in the male breast: a diagnostic challenge. Clin Cancer Invest J. 2016;5:345–348.
20.
SharmaRKaushalV. Pure mucinous carcinoma in male breast with axillary lymph node metastasis. Clin Cancer Investig J. 2016;5(1):40–42.
21.
SubikKLeeJFBaxter L, et al.“Immunohistochemically characterization of molecular classification of breast carcinoma and its relation with Ki-67. Clin Cancer Investig J. 2016;5:430–436.
22.
BalasundaramMJayaparakasRBhaskarSP. Clinical study of molecular hormonal receptor level status among carcinoma of breast in Karaikal population. Int Arch Integr Med. 2017;4:151–156.
23.
MwakigonjaARLushinaNEMwangaA. Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar Es Salaam, Tanzania. Infect Agents Cancer. 2017;12:1–12.
24.
DwivediSGargKCPrasadHN. Scientometric profile of global male breast cancer research. Current Sci. 2017;112:1814–1821.
25.
MannNMaTDaltonA. Neurofibromatosis type 1 and male breast cancer: emerging risk factor. J Surg Case Rep. 2017;2017(7):1–3.
26.
FentimanISFourquetAHortobagyiGN. Prognosis. In: Male Breast Cancer. Springer International; 2017:145.
27.
GeYSneigeNEltorkyMA, et al.Immunohistochemical characterization of subtypes of male breast. Breast Cancer Res. 2009;11(3):R28.
28.
ShaabanAMBallGRBrannanRA, et al.A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2012;133(3):949–958.
29.
ShahidsalesSErsiMF. Male breast cancer: a review of literature. Clin Med Rev. 2017;4(2):69–72.
30.
SørlieTTibshiraniRParkerJ, et al.Repeated observation of breast tumour subtypes in independent gene expression sets. Proc Natl Acad Sci U S A. 2003;100(14):8418–8423.
31.
SousaBMoserECardosoF. An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol. 2013;717(1-3):71–83.
32.
CardosoFBartlettJMSlaetsL. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG international male breast cancer program. Ann Oncol. 2018;29(2):P405–P417.
33.
WangFShuXMeszoelyI, et al.Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol. 2019;5(11):1589–1596.
34.
GaoYGoldbergJEYoungTK, et al.Breast cancer screening in high-risk men: a 12-year longitudinal observational study of male breast imaging utilization and outcomes. Radiology. 2019;293(2):282–291.
35.
HassettMJSomerfieldMRBakerER, et al.Management of male breast cancer: ASCO guideline. J Clin Oncol. 2020;38(16):1849–1863.
36.
JohanssonIKillanderFLinderholmBHedenfalkI. Molecular profiling of male breast cancer—lost in translation?Int J Biochem Cell Biol. 2014;53:526–535.
